Cinctive Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Cinctive Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-149,923	Closed	-$5.9M	–	523
2023 Q2	$5.9M	Buy	+149,923	New	+$5.29M	0.2%	177
2022 Q3	–	Sell	-43,800	Closed	-$421K	–	659
2022 Q2	$421K	Sell	43,800 -38,200	-47%	-$479K	0.02%	444
2022 Q1	$1.38M	Buy	82,000 +27,000	+49%	+$399K	0.05%	368
2021 Q4	$920K	Buy	55,000 +12,477	+29%	+$205K	0.04%	420
2021 Q3	$691K	Buy	+42,523	New	+$463K	0.03%	438

Cinctive Capital Management's ISEE Position: Q3 2023 in Review

Cinctive Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 149,923 shares — an estimated $5.9M sold.

Cinctive Capital Management first reported a position in ISEE in Q3 2021 and held it in 5 quarters. The position peaked at $5.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Cinctive Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cinctive Capital Management sold 149,923 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $5.9M.
Cinctive Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Cinctive Capital Management's IVERIC bio, Inc. Common Stock position peaked at $5.9M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Cinctive Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.